Liposomal mitoxantrone monotherapy in patients with relapsed or refractory mature T-cell and natural killer-cell neoplasms: A phase 2, multicenter, open-label, single-arm trial.
Gao Y, Huang Y, Zhang Q, Yang H, Li Y, Li Y, Zhou M, Yang R, Xu B, Liu L, Yang Y, Peng Z, Yu D, Zhou H, Zhang R, Zhang H, Qi J, Xi Y, Xing X, Wang Z, Jing H, Shuang Y, Zhang X, Ma L, Jin H, Lin L, Li C, Xue J, Liu Y, Yuan J, Huang H.
Gao Y, et al. Among authors: ma l.
Cancer. 2025 Jan 1;131(1):e35672. doi: 10.1002/cncr.35672.
Cancer. 2025.
PMID: 39748491
Clinical Trial.